Parkinsons Disease
Antibiotic Rifampicin Shows Promise For Fighting Parkinson's Disease In Laboratory Tests
19 years, 4 months ago
8451
0
Posted on Dec 06, 2004, 10 a.m.
By Bill Freeman
Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson's disease. The drug also dissolved existing fibrils in laboratory tests.
Researchers at the University of California, Santa Cruz, have shown that rifampicin, an antibiotic used to treat leprosy and tuberculosis, can prevent the formation of protein fibrils associated with the death of brain cells in people with Parkinson's disease. The drug also dissolved existing fibrils in laboratory tests.
http://www.sciencedaily.com/releases/2004/11/041130235031.htm
http://www.sciencedaily.com/releases/2004/11/041130235031.htm
